Asana, Inc.

Good afternoon, and thank you for attending the ASANA first quarter and fiscal year 2022 earnings call. My name is Amber, and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with a question and answer session at the end. If you would like to submit a question, please press star 1 on your telephone keypad at any time. I now have the pleasure of handing the conference over to our host, Catherine Blonde, Head of Investor Relations at Asana. Catherine, please proceed.

Good afternoon, and thank you for joining us on today's conference call to discuss the financial results of Asana's first quarter fiscal 2023. With me on today's call are Dustin Moskovitz, Asana's co-founder and CEO, Anne Rimondi, our Chief Operating Officer and Head of Business, and Tim Wan, our Chief Financial Officer. Today's call will include four booking statements. including statements regarding our financial outlook, market position, and growth opportunities.

Say goodbye to multiple daily insulin injections with the new Omnipod 5, the only tubeless automated insulin delivery system that integrates with Dexcom G6, automatically adjusting your insulin to help protect against highs and lows day or night. Don't wait to simplify life with diabetes. Get started today with no contract and no commitment. Go to Omnipod.com for risk information and instructions for use. Consult your healthcare provider before starting on Omnipod. Simplify diabetes. Simplify life.